Alignment Healthcare (ALHC) EBITDA (2020 - 2026)

Alignment Healthcare has reported EBITDA for 7 years, with the latest figure at $23.4 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 1360.31% year-over-year to $23.4 million; the trailing twelve-month figure through Mar 2026 stood at $66.4 million (up 272.43% YoY), and the FY2025 full-year result was $44.6 million, up 159.31% from the prior year.
• EBITDA for Q1 2026 stood at $23.4 million, up from -$2.4 million in the prior quarter.
• The five-year high for EBITDA was $29.8 million in Q2 2025, with the low at -$47.5 million in Q4 2022.
• Historically, EBITDA has averaged -$13.6 million across 5 years, with a median of -$15.7 million in 2024.
• Annual changes were most pronounced in 2023 — EBITDA tumbled 634.35% — and 2026, when it surged 1360.31%.
• Alignment Healthcare's EBITDA stood at -$47.5 million in 2022, then climbed by 23.97% to -$36.1 million in 2023, then soared by 56.38% to -$15.7 million in 2024, then jumped by 84.43% to -$2.4 million in 2025, then soared by 1053.67% to $23.4 million in 2026.
• The last three EBITDA figures came in at $23.4 million (Q1 2026), -$2.4 million (Q4 2025), and $15.7 million (Q3 2025), per Business Quant data.